Skip to main content

Peer Review reports

From: Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older

Original Submission
10 Feb 2022 Submitted Original manuscript
11 Mar 2022 Reviewed Reviewer Report
12 Mar 2022 Reviewed Reviewer Report
28 Mar 2022 Author responded Author comments - Hiroshi Kawakami
Resubmission - Version 2
28 Mar 2022 Submitted Manuscript version 2
29 Mar 2022 Author responded Author comments - Hiroshi Kawakami
Resubmission - Version 3
29 Mar 2022 Submitted Manuscript version 3
1 Apr 2022 Reviewed Reviewer Report
3 Apr 2022 Reviewed Reviewer Report
7 Apr 2022 Author responded Author comments - Hiroshi Kawakami
Resubmission - Version 4
7 Apr 2022 Submitted Manuscript version 4
10 Apr 2022 Author responded Author comments - Hiroshi Kawakami
Resubmission - Version 5
10 Apr 2022 Submitted Manuscript version 5
Publishing
14 Apr 2022 Editorially accepted
28 Apr 2022 Article published 10.1186/s12876-022-02284-z

You can find further information about peer review here.

Back to article page